The largest database of trusted experimental protocols

Cd31 coated magnetic beads

Manufactured by Thermo Fisher Scientific
Sourced in United States

CD31-coated magnetic beads are a type of lab equipment used for cell isolation and purification. These beads are coated with the CD31 (also known as PECAM-1) antibody, which binds to cells expressing the CD31 antigen, allowing for the selective isolation of these cells from a heterogeneous sample. The magnetic properties of the beads enable simple and efficient separation of the target cells using a magnetic field. These beads can be used in various cell biology and immunology applications that require the isolation of CD31-positive cells.

Automatically generated - may contain errors

6 protocols using cd31 coated magnetic beads

1

ECFC Isolation and Expansion Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study protocol was approved by the institutional review board of Duksung Women's University (IRB No. 2017-002-001). ECFCs were isolated from the adherent mononuclear cell (MNC) fraction of human peripheral blood using CD31-coated magnetic beads (Invitrogen, MA, USA) as described previously [10 (link)]. The isolated ECFCs were expanded on 1% gelatin-coated plates (BD Biosciences, NJ, USA) using endothelial growth medium-2 (EGM-2 without hydrocortisone; Lonza, MD, USA) supplemented with 10% fetal bovine serum (FBS; Atlas Biologicals, CO, USA) and 1% glutamine-penicillin-streptomycin (GPS; Gibco, MA, USA). ECFCs between passages 7 and 10 were used for all experiments.
+ Open protocol
+ Expand
2

Isolation and Expansion of ECFCs and MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study protocol was approved by the institutional review board of Duksung Women’s University (IRB No. 2017-002-01). The endothelial colony-forming cells (ECFCs) were isolated from human peripheral blood provided from one normal adult male donor. Some CD31-coated magnetic beads (Invitrogen, Waltham, MA, USA) were used to isolate ECFCs from the adherent mononuclear cell fraction of blood, as described in a previous report [19 (link)]. The isolated ECFCs were expanded on 1% gelatin-coated plates (BD Biosciences, Franklin Lakes, NJ, USA) using endothelial cell growth medium (EGM-2; Lonza, Basel, Switzerland) without hydrocortisone, supplemented with 10% fetal bovine serum (FBS; Atlas Biologicals, Fort Collins, CO, USA) and 1% glutamine–penicillin–streptomycin (GPS; Gibco, Waltham, MA, USA). Mesenchymal stem cells (MSCs) isolated from one normal human adult bone marrow were purchased from Lonza and then cultured using MSC growth medium (Lonza) supplemented with 10% FBS and 1% GPS. The ECFCs and MSCs between passages 7 and 10 were used for all experiments.
+ Open protocol
+ Expand
3

Isolation and Expansion of Human ECFCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endothelial colony-forming cells (ECFCs) were isolated from the adherent mononuclear cell fraction of human peripheral blood using CD31-coated magnetic beads (Invitrogen, MA, USA) as previously described [11 (link)]. Isolated ECFCs were expanded on 1% gelatin-coated plates (BD Biosciences, NJ, USA) using an endothelial cell growth medium MV 2 (EGM-MV 2 without hydrocortisone; PromoCell, Heidelberg, Germany) supplemented with 10% fetal bovine serum (Atlas Biologicals, CO, USA) and 1% glutamine-penicillin-streptomycin (Gibco, MA, USA). ECFCs between passages seven and ten were used in all of the experiments. The protocol for this section of the study was approved by the institutional review board of Duksung Women's University (IRB Nos. 2017-002-001 and 2018-007-006).
+ Open protocol
+ Expand
4

Isolation and Expansion of ECFC and MPC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical cord blood was obtained from the Brigham and Women’s Hospital in accordance with an Institutional Review Board-approved protocol and according to the Declaration of Helsinki. Informed consent was not obtained as cord blood was excess human material, normally discarded, and was obtained without identifiers. ECFC were isolated from the adherent cell fraction using CD31-coated magnetic beads (Invitrogen) as described30 (link). ECFC were expanded on fibronectin (FN)-coated plates (1 μg/cm2; Millipore, MA) using EGM-2 (without hydrocortisone; Lonza) supplemented with 20% fetal bovine serum (FBS; Hyclone) and 1x glutamine-penicillin-streptomycin (GPS; Cellgro). ECFC between passages 5 and 8 were used for all experiments. ECFC express CD31, VE-cadherin, VEGFR-2, but not CD90, CD45 or CD143 (link), 31 (link).
MPC were isolated from the MNC fraction of human adult bone marrow (Lonza). MNC fraction isolated using Ficoll-Paque (GE Healthcare) was seeded on 1% gelatin-coated plates using MSCGM medium (Lonza) supplemented to 10% FBS, 1x GPS. Unbound cells were removed at 48 hours, and the adherent cell fraction maintained in culture until 70% confluent. MPC were expanded in MSCGM medium supplemented to 10% FBS, 1x GPS. MPC between passages 5 and 8 were used for all experiments. MPC express CD90 and CD105 but not CD31, VE-cadherin, VEGFR-2, CD45 or CD143 (link), 31 (link).
+ Open protocol
+ Expand
5

Isolation and Expansion of Endothelial Colony-Forming Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study protocol was approved by the Institutional Review Board (IRB) of Duksung Women's University (IRB No. 2017-002-001, 2018-007-006). ECFCs were isolated from the adherent mononuclear cell fraction of human peripheral blood using CD31-coated magnetic beads (Invitrogen, Waltham, MA, USA) as described previously.14 (link) Isolated ECFCs were expanded on 1% gelatin-coated plates (BD Biosciences, Franklin Lakes, NJ, USA) using EC growth medium MV 2 (EGM-MV 2 without hydrocortisone; Promocell, Heidelberg, Germany) supplemented with 10% fetal bovine serum (FBS; Atlas Biologicals, Fort Collins, CO, USA) and 1% glutamine-penicillin-streptomycin (GPS; Gibco, Waltham, MA, USA). ECFCs obtained between passages 7 and 10 were used for all experiments.
+ Open protocol
+ Expand
6

Isolation and Expansion of ECFCs and MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study protocol was approved by the institutional review board of Duksung Women’s University (IRB No. 2017-002-001). Human peripheral blood was provided from the national biobank. ECFCs were isolated from the adherent mononuclear cell (MNC) fraction using CD31-coated magnetic beads (Invitrogen, MA, USA) as described in the previous report (Melero-Martin et al., 2008 (link)). The isolated ECFCs were expanded on 1% gelatin-coated plates (BD Biosciences, NJ, USA) using endothelial growth medium-2 (EGM-2; Lonza, MD, USA) without hydrocortisone supplemented with 10% fetal bovine serum (FBS; Atlas Biologicals, CO, USA) and 1% glutamine-penicillin-streptomycin (GPS; Gibco, MA, USA). In all experiments, ECFCs from passages 7 to 10 were used.
MSCs were obtained from the MNC fraction of human adult bone marrow (Lonza). MSCs were cultured in MSC growth medium (Lonza) containing 10% FBS and 1% GPS until 80% confluence was achieved. MSCs from passage numbers 5 to 8 were used.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!